References
1. Zamorano JL. Lancellotti P, Muñoz DR, et al; ESC Scientific Document
Group. 2016. ESC Position Paper on cancer treatments and cardiovascular
toxicity developed under the auspices of the ESC Committee for Practice
Guidelines. Eur Heart J 2016:37:2768-280.
2. Jurcut R, Wildiers H, Ganame J, et al. Strain rate imaging defects
early cardiac effects of pegylated liposomal Doxorubicin as adjuvant
therapy in elderly patients with breast cancer. J Am Soc Echocardiogr
2008:21:1283–9.
3. Santoro C, Arpino G, Esposito R, et al. 2D and 3D strain for
detection of subclinical anthracycline cardiotoxicity in breast cancer
patients: a balance with feasibility. Eur Heart J – Cardiovasc Imaging
2017:18(8):930-936.
4. Sawaya H, Sebag IA, Plana JC, et al. Assessment of echocardiography
and biomarkers for the extended prediction of cardiotoxicity in patients
treated with anthracyclines, taxanes, and trastuzumab. Circ Cardiovasc
Imaging 2012:5:596-603.
5. Geyer H, Caracciolo G, Abe H, et al. Assessment of myocardial
mechanics using speckle tracking echocardiography: fundamentals and
clinical applications. J Am Soc Echocardiography 2010;23:351-369.
6. Lester SJ, Tajik AJ, Nishimura RA, et al. Unlocking the mysteries of
diastolic function: deciphering the Rosetta Stone 10 years later.J Am Coll Cardiol 2008:51:679–89.
7. Plana JC, Galderisi M, Barac A, et al. Expert Consensus for
Multimodality Imaging Evaluation of Adult Patients during and after
Cancer Therapy: A Report from the American Society of Echocardiography
and the European Association of Cardiovascular Imaging. J Am Soc
Echocardiogr 2014:911–39.
8. Nagueh SF, Middleton KJ, Kopelen HA, et al. Doppler tissue imaging: A
noninvasive technique for evaluation of left ventricular relaxation and
estimation of filling pressures. J Am Coll Cardiol
1997:30:1527–33.
9. Ommen SR, Nishimura RA, Appleton CP, et al. Clinical utility of
Doppler echocardiography and tissue Doppler imaging in the estimation of
left ventricular filling pressures: A comparative simultaneous
Doppler-catheterization study. Circulation 2000:102:1788–94.
10. Dokainish H, Zoghbi WA, Lakkis NM, et al. Optimal non-invasive
assessment of LV filling pressures: A comparison of tissue Doppler
echocardiography and BNP in patients with pulmonary artery catheters.
Circulation 2004:109:2432–9.
11. Nagueh SF, Smiseth OA, Appleton CP, et al. Recommendations for the
Evaluation of Left Ventricular Diastolic Function by Echocardiography:
An Update from the American Society of Echocardiography and the European
Association of Cardiovascular Imaging. J Am Soc Echocardiogr
2016:Apr;29(4):277-314.
12. Lassen MCH, Biering-Sørensen SR, Olsen FJ, et al. Ratio of
transmitral early filling velocity to early diastolic strain rate
predicts long-term risk of cardiovascular morbidity and mortality in the
general population. Eur Heart J 2019:Feb7;40(6):518-525.
13. Ersbøll M, Andersen MJ, Valeur N, et al. Early diastolic strain rate
in relation to systolic and diastolic function and prognosis in acute
myocardial infarction: a two-dimensional speckle-tracking study. Eur
Heart J Volume 35, Issue 10, 7 March 2014, Pages 648–656.
14. Morris DA, Boldt LH, Eichstädt H, et al. Myocardial systolic and
diastolic performance derived by 2-dimensinoal speckle tracking
echocardiography in heart failure with normal left ventricular ejection
fraction. Circ Heart Fail 2012:Sep1;5(5):610-20.
15. Ponikowski P, Voors AA, Anker SD, et
al; ESC Scientific Document Group. ESC Scientific Document Group. 2016
ESC Guidelines for the diagnosis and treatment of acute and chronic
heart failure: The Task Force for the diagnosis and treatment of acute
and chronic heart failure of the European Society of Cardiology (ESC)
Developed with the special contribution of the Heart Failure Association
(HFA) of the ESC. Eur Heart J Volume 37, Issue 27, 14 July
2016,2129–2200.
16. Lang RM, Bierig M, Devereux RB, et al; American Society of
Echocardiography’s Nomenclature and Standards Committee; Task Force
on Chamber Quantification; American College of Cardiology
Echocardiography Committee; American Heart Association; European
Association of Echocardiography, European Society of Cardiology.
Recommendations for chamber quantification. Eur J Echocardiogr
2006:7:79–10817.
17. Teo SG, Yang H, Chai P, et al. Impact of left ventricular diastolic
dysfunction on left atrial volume and function: a volumetric analysis.
Eur J Echocardiogr 2010:11:38–43
18. Charbonnel C, Convers-Domart R, Rigaudeau S. Assessment of global
longitudinal strain at low-dose anthracycline-based chemotherapy, for
the prediction of subsequent cardiotoxicity. Eur Heart J Cardiovasc
Imaging 2017:18:392-401.
19. Laufer-Perl M, Arnold JH, Mor L, et al. The association of reduced
global longitudinal strain with cancer therapy-related cardiac
dysfunction among patients receiving cancer therapy. Clin Res
Cardiol 2019:Jun18.
20. Stoodley PW, Richards DA, Boyd A, et al. Altered left ventricular
longitudinal diastolic function correlates with reduced systolic
function immediately after anthracycline chemotherapy. Eur Heart J
Cardiovasc Imaging 2013:March;14(3):228-34.
21. Park JH, Marwick TH. Use and Limitations of E/e’ to Assess Left
Ventricular Filling Pressure by Echocardiography. J Cardiovasc
Ultrasound 2011:Dec;19(4):169-173.
22. Wang J, Khoury DS, Thohan V, et al. Global diastolic strain rate for
the assessment of left ventricular relaxation and filling pressures.
Circulation 2007:Mar 20;115(11):1376-83.
23. Lee JH, Park JH. Strain Analysis of the Right Ventricle Using
Two-dimensional Echocardiography. J Cardiovasc Imaging
2018:Sep;26(3):111-124.
24. Redfield MM, Jacobsen SJ, Burnett JC, et al. Burden of systolic and
diastolic ventricular dysfunction in the community: appreciating the
scope of the heart failure epidemic. JAMA 2003:289:194–202.
25. Laufer-Perl M, Derakhshesh M, Milwidsky A, et al. Usefulness of
global longitudinal strain for early identification of subclinical left
ventricular dysfunction in patients with active cancer. Am J Cardiol
2018;00:1-6.
26. Ohtani K, Fujino T, Ide T, et al. Recovery from left ventricular
dysfunction was associated with the early introduction of heart failure
medical treatment in cancer patients with anthracycline-induced
cardiotoxicity. Clin Res Cardiol 108:600–611.
27. Tocchetti CG, Cadeddu C, Di Lisi D, et al. From Molecular Mechanisms
to Clinical Management of Antineoplastic Drug-Induced Cardiovascular
Toxicity: A Translational Overview. Antioxid Redox Signal
2019:30(18):2110–2153.
28. Hare JL, Brown JK, Leano R, et al. Use of myocardial deformation
imaging to detect preclinical myocardial dysfunction before conventional
measures in patients undergoing breast cancer treatment with
trastuzumab. Am Heart J 2009:158:294–301.
29. Ho E, Brown A, Barrett P, et al. Subclinical anthracycline- and
trastuzumab-induced cardiotoxicity in the long-term follow-up of
asymptomatic breast cancer survivors: a speckle tracking
echocardiographic study. Heart 96:701–707,2010.
30. Pizzino F, Vizzari G, Qamar R, et al. Multimodality imaging in
cardiooncology. J Oncol 2015:263950.
Figure 1 legend: Measurement of Diastolic strain time (ms).
A figure that shows how Diastolic strain time (ms) was calculated.
Figure 2 legend: ROC curves for change in Basal Diastolic time
alone and as part of the multivariate model for prediction of
significant global longitudinal strain (GLS) decrease.
A graph showing ROC curves for predicting significant GLS change between
the third and first echo using (green) Basal diastolic time (Dst) change
alone with an AUC of 0.726, 95% CI [0.515, 0.937] and (blue) using
the entire Multivariate model with an AUC of 0.950, 95%CI [0.888,
1], p value for differences between AUCs: 0.0
AUC of the ROC for Basal Dst change alone showed statistically
significant, although modest comparing to the entire model, supporting
that other parts of the model show a different aspect of GLS reduction
prediction.
Abbreviations : AUC, area under curve; CI, confidence interval;
GLS, global longitudinal strain; ROC, receiver operating characteristic;